> | KB | > | Results |
Preamble
Preamble
Preamble
Pharmaceuticals
Objectives
Objective
Objective
Notification
Non-Parties
Non-Parties
Natinoal Focal Points and Competent National Authorities
Monitoring the Utilization of Genetic Resources
Monitoring and Reporting
Monitoring and Reporting
Monetary and Non-Monetary Benefits
Model Contractual Clauses
Liability and Redress
Jurisdictional Scope
Information Sharing and the Biosafety Clearing-House
Information Required in Notifications Under Article 8, 10 and 13
Information Required Concerning Living Modified Organisms Intended for Direct Use as Food or Feed, or for Processing Under Article 11
Incentive Measures
In-situ Conservation
Impact Assessment and Minimizing Adverse Impacts
Illegal Transboundary Movements
Identification and Monitoring
Identification and Monitoring
Handling, Transport, Packaging and Identification
Handling of Biotechnology and Distribution of its Benefits
Global Multilateral Benefit-Sharing Mechanism
General Provisions
General Measures for Conservation and Sustainable Use
Financial Resources
Financial Mechanism and Resources
Financial Mechanism and Resources
Financial Mechanism
Financial Interim Arrangements
Fair and Equitable Benefit-Sharing
Exchange of Information
Ex-situ Conservation
Entry into Force
Entry Into Force
Entry Into Force
Domestic Legislation or Regulatory Requirements on Access and Benefit-Sharing for Traditional Knowledge Associated with Genetic Resources
Depositary
Decision Procedure
Cooperation
Contribution to Conservation and Sustainable Use
Confidential Information
Conference of the Parties Serving as the Meeting of the Parties to this Protocol